What changed
$UPS — BUY 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $21.2B | EPS $1.07 vs $1.02 🟢 | Margin 6.0%
💡 Consensus expects volumes to remain under pressure from inflation and a slowing economy, but UPS's cost-cutting and mix shift to higher-margin healthcare/SMB segments are being underestimated. The $0.05 beat was dismissed as one-off; we see it as the start of a positive revision cycle.
📉 Reward/risk: 2.83:1
🏢 Business Quality: 7/10
📊 Valuation: rich — P/E ~25.5x trailing vs. 5-year avg ~20x; EV/EBITDA ~12x vs. peer median ~10x; upside case relies on earnings growth and multiple re-rating to...
🔮 Catalyst: Q2 2026 earnings release
💰 Entry: $109.31, stop $102, target $130
⚖️ Buy — Q1 beat is underappreciated; Q2 catalyst and favorable risk/reward support long position ahead of earnings.
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/UPS0625